Treatment for Post-hemorrhagic Ventricular Dilatation: A Multiple-Treatment Meta-Analysis.

Area of Science:

• Neonatal neurology
• Pediatric neurosurgery
• Evidence-based medicine

Background:

• Post-hemorrhagic ventricular dilatation (PHVD) poses significant risks for premature infants, leading to death or long-term neurodevelopmental disability.
• Limited therapeutic options have been rigorously evaluated for managing PHVD in preterm neonates.

Purpose of the Study:

• To conduct a systematic review and multiple-treatment meta-analysis (NMA) evaluating interventions for PHVD in premature infants.
• To identify the most effective treatment strategy to prevent death or neurodevelopmental impairment.

Main Methods:

• Systematic literature search of PubMed, EMBASE, and Cochrane Library for intervention trials in preterm infants with PHVD.
• Bayesian random-effects network meta-analysis using Markov chain Monte Carlo methods.
• Calculation of Surface Under the Cumulative Ranking (SUCRA) curves to rank treatment probabilities.

Main Results:

• Ten trials involving 700 infants were analyzed, comparing seven intervention categories.
• No single intervention reached conventional statistical significance in pairwise comparisons.
• Drainage Irrigation and Fibrinolytic Therapy (DRIFT) demonstrated the highest probability (82.1%) of being the most effective treatment for the primary outcome.

Conclusions:

• PHVD remains a critical concern in neonatal care, necessitating further research into effective therapies.
• Current NMA findings indicate DRIFT as the most promising intervention for improving outcomes in infants with intraventricular hemorrhage-related PHVD.